As a possible explanation, the glycosylation of MUCL1 might be sufficiently mediated by ST6GAL1 gene alone —whose expression still remains slightly induced in vitD3-tolDC from MS patient samples—. This evidence concerns the gene ST6GAL1 and myeloid sarcoma.